KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
300633 Sonoscape Medical Corp.
- 33.78
- -0.56-1.63%
Market Closed Dec 13 15:00 CST
14.62BMarket Cap60.21P/E (TTM)
34.42High33.40Low50.65KlotVolume34.40Open34.34Pre Close170.73MTurnover1.17%Turnover Ratio32.17P/E (Static)432.71MShares49.0852wk High4.68P/B14.62BFloat Cap25.0452wk Low41.21Limit Up432.71MShs Float62.30Historical High27.47Limit Down2.97%Amplitude5.48Historical Low0.32Dividend TTM33.71Avg Price33.55KlotAsk0.95%Div YieldTTM100Lot Size15.50KlotBid
Sonoscape Medical Corp. Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -4.74%1.4B | -2.94%1.01B | 1.33%479.33M | 20.29%2.12B | 17.31%1.47B | 24.87%1.04B | 27.63%473.03M | 22.02%1.76B | 33.10%1.25B | 30.00%835.53M |
| Operating revenue | -4.74%1.4B | -2.94%1.01B | 1.33%479.33M | 20.29%2.12B | 17.31%1.47B | 24.87%1.04B | 27.63%473.03M | 22.02%1.76B | 33.10%1.25B | 30.00%835.53M |
| Other operating revenue | ---- | 105.12%9.92M | ---- | 17.89%12.65M | ---- | -16.46%4.84M | ---- | 15.80%10.73M | ---- | -12.48%5.79M |
| Total operating cost | 17.92%1.35B | 14.56%872.75M | 9.89%394.01M | 17.31%1.67B | 11.87%1.15B | 13.58%761.81M | 11.87%358.55M | 17.09%1.42B | 20.39%1.02B | 19.21%670.7M |
| Operating cost | 1.77%467.2M | 1.92%329.85M | -1.24%146.69M | 11.05%648.55M | 3.99%459.09M | 11.35%323.63M | 0.48%148.53M | 23.95%584.04M | 37.83%441.48M | 31.43%290.63M |
| Operating tax surcharges | -27.68%13.16M | -28.74%9.61M | -32.97%4.34M | 60.53%24.44M | 69.96%18.2M | 79.41%13.48M | 56.40%6.48M | 32.10%15.22M | 42.57%10.71M | 46.03%7.51M |
| Operating expense | 30.06%458.78M | 24.10%287.29M | 16.30%122.91M | 23.92%524.36M | 23.59%352.75M | 24.38%231.5M | 44.05%105.68M | 15.45%423.16M | 8.48%285.41M | 12.60%186.12M |
| Administration expense | 18.89%100.94M | 13.44%62.82M | 37.34%34.55M | 30.95%128.33M | 20.86%84.9M | 29.76%55.38M | 43.92%25.15M | 7.87%98M | 9.08%70.25M | 3.17%42.67M |
| Financial expense | 16.75%-27.36M | 9.30%-29M | -120.62%-16.12M | -49.46%-44.68M | -24.12%-32.86M | -139.92%-31.97M | -464.05%-7.3M | -427.65%-29.89M | -954.30%-26.47M | -522.45%-13.33M |
| -Interest expense (Financial expense) | 5.76%4.64M | -28.71%2.41M | -45.32%841.32K | 36.41%5.05M | 450.91%4.38M | 3,614.14%3.37M | 1,613.03%1.54M | -33.29%3.7M | -78.37%795.82K | -97.35%90.86K |
| -Interest Income (Financial expense) | -71.46%-36.83M | -18.56%-28.19M | -11.98%-17.01M | -161.64%-46.67M | -125.78%-21.48M | -288.26%-23.78M | -340.92%-15.19M | -205.72%-17.84M | -157.85%-9.51M | -113.75%-6.12M |
| Research and development | 28.33%338.31M | 24.96%212.18M | 27.03%101.64M | 16.81%384.26M | 8.59%263.62M | 8.09%169.8M | 5.69%80.01M | 25.05%328.96M | 26.27%242.76M | 24.16%157.09M |
| Credit Impairment Loss | 61.85%-8.44M | 24.88%-15.35M | -4.92%-7.66M | 28.01%-14.34M | 34.80%-22.11M | 10.82%-20.43M | 53.69%-7.3M | -93.70%-19.91M | -182.45%-33.92M | -89.28%-22.91M |
| Asset Impairment Loss | -11.91%-10.12M | -11.91%-10.12M | ---- | -27.35%-51.12M | -14.93%-9.04M | -14.93%-9.04M | ---- | 59.42%-40.14M | -237.67%-7.87M | -267.05%-7.87M |
| Other net revenue | 148.27%68.55M | 284.51%36.86M | -26.44%25.71M | -49.51%19.83M | -28.54%27.61M | -51.73%9.59M | 473.45%34.95M | 335.88%39.27M | -26.31%38.64M | -43.97%19.86M |
| Fair value change income | 136.10%3.91M | 114.85%2.47M | -96.56%113.97K | 95.54%-175.54K | -524.80%-10.82M | -435.34%-16.61M | 465.17%3.31M | -224.20%-3.93M | 1,119.98%2.55M | 677.23%4.95M |
| Invest income | 50.55%-2.49M | -202.09%-2.94M | -191.39%-1.95M | -236.88%-12.67M | -242.21%-5.03M | 309.46%2.88M | 59.48%2.13M | -21.82%9.25M | -51.16%3.54M | -85.61%703.09K |
| Asset deal income | -41.74%11.86K | ---- | ---- | 102.73%20.35K | 139.92%20.35K | 92.23%-3.96K | 2,385.44%20.35K | -289.38%-744.35K | -197.77%-50.99K | ---50.99K |
| Other revenue | 14.85%85.67M | 18.97%62.81M | -4.29%35.2M | 3.54%98.11M | 0.29%74.6M | 17.22%52.79M | 71.71%36.78M | 21.90%94.75M | 25.52%74.38M | 1.95%45.04M |
| Operating profit | -66.92%115.7M | -39.27%176.81M | -25.69%111.03M | 24.16%474.81M | 31.58%349.74M | 57.62%291.12M | 165.82%149.43M | 77.33%382.43M | 87.32%265.8M | 59.83%184.69M |
| Add:Non operating Income | 289.88%766.29K | 1,159.73%636.88K | 1,783.07%600.31K | 99.79%218.62K | 105.53%196.54K | 39.12%50.56K | 157.49%31.88K | -99.73%109.43K | 173.53%95.63K | -52.33%36.34K |
| Less:Non operating expense | -11.88%877.2K | 178.79%814.36K | -65.72%97.16K | 101.92%1.2M | 117.46%995.42K | -30.68%292.1K | 296.49%283.42K | -60.27%595.35K | 54.14%457.75K | 417.37%421.36K |
| Total profit | -66.87%115.59M | -39.28%176.63M | -25.23%111.54M | 24.06%473.83M | 31.46%348.94M | 57.82%290.88M | 165.66%149.18M | 50.25%381.94M | 87.41%265.44M | 59.50%184.31M |
| Less:Income tax cost | -76.67%6.61M | -65.99%6.06M | 6.02%11.35M | 59.82%19.39M | 41.34%28.32M | 88.08%17.82M | 110.79%10.7M | 74.20%12.13M | 779.97%20.04M | 45.67%9.47M |
| Net profit | -66.01%108.99M | -37.53%170.57M | -27.65%100.19M | 22.88%454.44M | 30.65%320.62M | 56.18%273.06M | 171.11%138.47M | 49.57%369.81M | 76.09%245.4M | 60.33%174.84M |
| Net profit from continuing operation | -66.01%108.99M | -37.53%170.57M | -27.65%100.19M | 22.88%454.44M | 30.65%320.62M | 56.18%273.06M | 171.11%138.47M | 49.57%369.81M | 76.09%245.4M | 60.33%174.84M |
| Net profit of parent company owners | -66.01%108.99M | -37.53%170.57M | -27.65%100.19M | 22.88%454.44M | 30.65%320.62M | 56.18%273.06M | 171.11%138.47M | 49.57%369.81M | 76.09%245.4M | 60.33%174.84M |
| Earning per share | ||||||||||
| Basic earning per share | -66.26%0.252 | -38.01%0.3956 | -28.12%0.2326 | 23.26%1.06 | 30.21%0.7469 | 56.19%0.6382 | 171.02%0.3236 | 38.71%0.86 | 64.64%0.5736 | 49.89%0.4086 |
| Diluted earning per share | -66.22%0.2511 | -37.96%0.3939 | -28.01%0.2318 | 22.09%1.05 | 29.59%0.7433 | 55.38%0.6349 | 169.68%0.322 | 38.71%0.86 | 64.64%0.5736 | 49.89%0.4086 |
| Other composite income | -67.67%2.33M | -114.50%-291.5K | 366.56%1.66M | -67.16%5.21M | -56.76%7.21M | -78.54%2.01M | 25.04%-623.61K | 424.84%15.86M | 811.41%16.68M | 1,423.03%9.37M |
| Other composite income of parent company owners | -67.67%2.33M | -114.50%-291.5K | 366.56%1.66M | -67.16%5.21M | -56.76%7.21M | -78.54%2.01M | 25.04%-623.61K | 424.84%15.86M | 811.41%16.68M | 1,423.03%9.37M |
| Total composite income | -66.04%111.32M | -38.10%170.28M | -26.11%101.85M | 19.18%459.65M | 25.09%327.83M | 49.33%275.07M | 174.36%137.85M | 59.13%385.67M | 85.62%262.08M | 67.97%184.2M |
| Total composite income of parent company owners | -66.04%111.32M | -38.10%170.28M | -26.11%101.85M | 19.18%459.65M | 25.09%327.83M | 49.33%275.07M | 174.36%137.85M | 59.13%385.67M | 85.62%262.08M | 67.97%184.2M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.